Cerus Quick Ratio (CERS) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Cerus Corporation  (NASDAQ: CERS)

Cerus's Quick Ratio

CERS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 0.2 below Cerus's average Quick Ratio.

Within Medical Equipment & Supplies industry 171 other companies have achieved higher Quick Ratio than Cerus in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 2049 to 3352.

Explain Quick Ratio?
How much Cash & cash equivalents CERS´s has?
What are CERS´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CERS/financial-strength
https://api.csimarket.com/api/v1/companies/CERS/fundamentals
https://api.csimarket.com/api/v1/companies/CERS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
CERS Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change -9.53 %
Y / Y Cash & cash equivalent Change -79.18 %
Quick Ratio MRQ 0.2
CERS's Total Ranking # 3352
Seq. Current Liabilities Change -6.74 %
Seq. Cash & cash equivalent Change -9.07 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 172
Healthcare Sector # 819
Overall Market # 3352


Quick Ratio Statistics
High Average Low
7.36 2.25 0.21
(Mar 31 2013)   (Jun 30 2026)




Financial Statements
Cerus's Current Liabilities $ 80 Millions Visit CERS's Balance sheet
Cerus's Cash & cash equivalent $ 16 Millions Visit CERS's Balance sheet
Source of CERS's Sales Visit CERS's Sales by Geography


Cumulative Cerus's Quick Ratio

CERS's Quick Ratio for the trailling 12 Months

CERS Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 22.18 %
Y / Y Cash & cash equivalent TTM Growth -37.83 %
Quick Ratio TTM 0.53
Total Ranking TTM # 4098
Seq. Current Liabilities TTM Growth -2.2 %
Seq. Cash & cash equivalent TTM Growth -23.93 %


On the trailing twelve months basis In spite of the year on year decrease in CERS's Current Liabilities to $80.01 millions, cumulative Quick Ratio to 0.53 below the CERS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Cerus. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3881 to 4098.

Explain Quick Ratio?
How much Cash & cash equivalents CERS´s has?
What are CERS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 909
Within the Market # 4098


trailing twelve months Quick Ratio Statistics
High Average Low
2.05 0.76 0.21
(Mar 31 2016)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Baxter International Inc   0.52 $ 1,976.000  Millions$ 3,809.000  Millions
Infusystem Holdings Inc  0.51 $ 9.108  Millions$ 17.873  Millions
Stryker Corp  0.50 $ 3,271.000  Millions$ 6,500.000  Millions
Msa Safety Inc  0.50 $ 187.248  Millions$ 373.698  Millions
Teleflex Incorporated  0.50 $ 454.065  Millions$ 917.102  Millions
Sonoma Pharmaceuticals Inc   0.46 $ 4.609  Millions$ 9.944  Millions
P3 Health Partners Inc   0.46 $ 43.900  Millions$ 95.593  Millions
Avita Medical Inc   0.46 $ 10.500  Millions$ 23.037  Millions
Alphatec Holdings Inc   0.44 $ 79.936  Millions$ 180.767  Millions
Steris Plc  0.44 $ 531.100  Millions$ 1,207.800  Millions
Sanuwave Health Inc   0.40 $ 6.569  Millions$ 16.394  Millions
Novocure Limited  0.38 $ 102.738  Millions$ 270.659  Millions
Cadre Holdings inc   0.36 $ 63.916  Millions$ 178.051  Millions
U S Physical Therapy Inc  0.35 $ 38.225  Millions$ 109.218  Millions
Tela Bio Inc   0.31 $ 22.664  Millions$ 73.706  Millions
Tandem Diabetes Care Inc   0.28 $ 72.840  Millions$ 256.075  Millions
Ufp Technologies Inc   0.27 $ 20.625  Millions$ 77.359  Millions
Docgo Inc   0.26 $ 20.569  Millions$ 79.655  Millions
Bausch and Lomb Corp  0.25 $ 513.000  Millions$ 2,019.000  Millions
Accuray Incorporated  0.25 $ 42.254  Millions$ 170.106  Millions
Cerus Corporation  0.20 $ 16.350  Millions$ 80.006  Millions
Bioventus Inc   0.19 $ 30.709  Millions$ 159.282  Millions
Dentsply Sirona Inc   0.15 $ 195.000  Millions$ 1,312.000  Millions
Boston Scientific Corporation  0.13 $ 904.000  Millions$ 7,150.000  Millions
Solventum Corporation  0.13 $ 451.000  Millions$ 3,575.000  Millions
The Pennant Group Inc   0.12 $ 18.389  Millions$ 151.730  Millions
Zimmer Biomet Holdings Inc   0.11 $ 399.900  Millions$ 3,502.400  Millions
Integer Holdings Corporation  0.07 $ 14.135  Millions$ 201.125  Millions

Date modified: 2026-11-03T09:56:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.